MoneyWorks4Me

Mangalam Drugs & Organics informs about secretarial compliance report

25 May 2026 Evaluate

In terms of provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, Mangalam Drugs & Organics has informed that it enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..